EPAS1 and adrenal gland pheochromocytoma: However, the recent series by Agarwal et al. found a higher rate of genetic mutations in composite vs classic PCC (47 vs 23%) across MEN2/4, SDHx, VHL, NF1, and EPAS1 (3).